Literature DB >> 34036383

Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.

Yi Zhang1, Huan Ma2, Chang Chen1.   

Abstract

An increasing number of studies have shown that long non‑coding RNAs (lncRNAs) are crucially involved in tumorigenesis. However, the biological functions, underlying mechanisms and clinical value of lncRNA PC‑esterase domain containing 1B‑antisense RNA 1 (PCED1BAS1) in pancreatic ductal adenocarcinoma (PDAC) have not been determined, to the best of our knowledge. In the present study, the expression of PCED1BAS1, microRNA (miR)‑411‑3p and hypoxia inducible factor (HIF)‑1α mRNA in 47 cases of PDAC tissues were detected using reverse transcription‑quantitative (RT‑q)PCR. Moreover, the effects of PCED1BAS1 on the biological behaviors of PDAC cells were assessed using Cell Counting Kit‑8, EdU staining and Transwell assays. Bioinformatics analysis, RT‑qPCR, western blotting, dual luciferase reporter gene and RNA immunoprecipitation assays were performed to determine the regulatory relationships between PCED1BAS1, miR‑411‑3p and HIF‑1α. We demonstrated that PCED1BAS1 was significantly upregulated in PDAC tumor tissues, and its expression was associated with advanced Tumor‑Node‑Metastasis stage and lymph node metastasis. PCED1BAS1 knockdown inhibited PDAC cell proliferation, invasion as well as epithelial‑mesenchymal transition (EMT) in vitro. Mechanistically, PCED1BAS1 was shown to target miR‑411‑3p, resulting in the upregulation of HIF‑1α. In conclusion, PCED1BAS1 expression was upregulated in PDAC tissues and cells, and it participated in promoting the proliferation, invasion and EMT of cancer cells by modulating the miR‑411‑3p/HIF‑1α axis.

Entities:  

Keywords:  PC‑esterase domain containing 1B‑antisense RNA 1; hypoxia inducible factor‑1α; microRNA‑411‑3p; pancreatic ductal adenocarcinoma

Year:  2021        PMID: 34036383     DOI: 10.3892/or.2021.8085

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer.

Authors:  Jichuan Xu; Jian Xu; Xinyuan Liu; Jianxin Jiang
Journal:  Cell Death Discov       Date:  2022-06-14

Review 2.  LncRNAs as epigenetic regulators of epithelial to mesenchymal transition in pancreatic cancer.

Authors:  Yan Ma; Yang Di; Qiuyue Li; Qilin Zhan; Xiaomeng He; Shanshan Liu; Heng Zou; Christopher Corpe; Litian Chen; Jin Wang
Journal:  Discov Oncol       Date:  2022-07-11

3.  Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.

Authors:  Yue Qiu; Hong-Tao Wang; Xi-Fan Zheng; Xing Huang; Jin-Zhi Meng; Jun-Pu Huang; Zhen-Pei Wen; Jun Yao
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

Review 4.  Long Noncoding RNA and Circular RNA: Two Rising Stars in Regulating Epithelial-Mesenchymal Transition of Pancreatic Cancer.

Authors:  Xiaoying Yang; Cheng Qin; Bangbo Zhao; Tianhao Li; Yuanyang Wang; Zeru Li; Tianyu Li; Weibin Wang
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

Review 5.  Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer.

Authors:  Lorenzo F Sempere; Katherine Powell; Jatin Rana; Andrew A Brock; Thomas D Schmittgen
Journal:  Cancer Metastasis Rev       Date:  2021-09-30       Impact factor: 9.264

6.  Long non-coding RNA PCED1B antisense RNA 1 promotes gastric cancer progression via modulating microRNA-215-3p / C-X-C motif chemokine receptor 1 axis.

Authors:  Junyu Ren; Ning Xu; Ruize Zhou; Fengchang Huang; Hongbin Zhang; Wenliang Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis.

Authors:  Jianfeng Liu; Jun Qian; Qi Mo; Liming Tang; Qiang Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 8.  Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities.

Authors:  Aditi Kulkarni; Sharan Gayathrinathan; Soumya Nair; Anamika Basu; Taslim A Al-Hilal; Sourav Roy
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

9.  Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.

Authors:  Shimaa Sherif; Raghvendra Mall; Hossam Almeer; Adviti Naik; Abdulaziz Al Homaid; Remy Thomas; Jessica Roelands; Sathiya Narayanan; Mahmoud Gasim Mohamed; Shahinaz Bedri; Salha Bujassoum Al-Bader; Kulsoom Junejo; Davide Bedognetti; Wouter Hendrickx; Julie Decock
Journal:  J Transl Med       Date:  2022-09-30       Impact factor: 8.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.